Borderline Personality Disorder

Clinical picture

• Frantic efforts to avoid real or imagined abandonment dominate, so a cancelled appointment can precipitate crisis, rage or self-injury.
• Relationships oscillate between idealization and devaluation, and clinicians typically notice strong countertransference pulls in both directions.
• Affective instability shifts within hours rather than days, most often among dysphoria, irritability and anxiety rather than toward euphoria.
• Non-suicidal self-injury such as cutting or burning relieves numbness or tension; roughly 75% attempt suicide and 8-10% eventually die by suicide.
• Chronic emptiness, unstable self-image, and transient stress-related paranoia or dissociation lasting minutes to hours are characteristic.
• Impulsivity spans spending, sex, substance use, reckless driving and binge eating, and is scored separately from self-harming behavior.

Criteria snapshot

• Requires five or more of nine criteria spanning affective, interpersonal, behavioral and identity domains, present since early adulthood.
• The pattern must be pervasive across contexts and stable over time rather than episodic, which separates it from mood-episode phenomena.
• Recurrent suicidal or self-mutilating behavior is a distinct criterion from impulsivity, and both may be counted toward the threshold.
• Diagnosis before age 18 is explicitly permitted when the features have been present for at least one year and are unlikely to be developmental.
• The Section III alternative model rates self and interpersonal dysfunction plus traits such as emotional lability, anxiousness and impulsivity.

Neurobiology

• Heritability runs 40-60%, with amygdala hyperreactivity and reduced prefrontal and anterior cingulate top-down control driving affective storms.
• Reduced hippocampal and amygdala volumes with altered frontolimbic functional connectivity are the most replicated structural imaging findings.
• Blunted endogenous opioid tone may explain chronic emptiness and the analgesic quality of self-injury, alongside reduced pain sensitivity under stress.
• HPA axis dysregulation with abnormal dexamethasone suppression follows the early-life adversity reported by a majority of patients.
• Serotonergic hypofunction tracks impulsive aggression, while dopaminergic dysregulation is linked to transient psychotic-like and dissociative symptoms.
• Oxytocin effects are paradoxical, since intranasal oxytocin can reduce rather than increase trust in patients with high rejection sensitivity.

Psychology

• Linehan's biosocial theory holds that an emotionally vulnerable temperament transacting with an invalidating environment yields pervasive dysregulation.
• Disorganized attachment and unresolved trauma generate hyperactivated attachment strategies, so closeness and abandonment both register as threats.
• Mentalization failure under attachment stress collapses the distinction between internal states and external reality, driving misreading of intent.
• Splitting and projective identification defend against intolerable ambivalence and account for staff splitting on inpatient units.
• Self-injury and impulsive acts are negatively reinforced by immediate affect relief, which makes them highly resistant to insight alone.

Differential & comorbidity

• Bipolar II is distinguished by sustained episodes lasting days to weeks with sleep and energy change, versus reactive shifts lasting hours in BPD.
• Complex PTSD, ADHD, substance use disorders and antisocial personality disorder overlap heavily and are usually better formulated as comorbid.
• Comorbidity rates are high: major depression near 80%, PTSD 30-50%, substance use near 50%, eating disorders near 30%, and other personality disorders.
• Risk management requires separating chronic suicide risk from acute-on-chronic escalation, since repeated brief hospitalization can be iatrogenic.
• Screen for trauma history, intimate partner violence, and prescribing hazards including opioid and benzodiazepine dependence or stockpiling.

Pharmacologic treatment

• No medication is FDA-approved for BPD, and guidelines place psychotherapy first with pharmacotherapy reserved for comorbidity or acute crisis.
• Mood stabilizers such as lamotrigine and topiramate showed early signal for anger and impulsivity, but the largest lamotrigine trial was negative.
• Second-generation antipsychotics such as aripiprazole 5-15 mg/day or quetiapine reduce anger and cognitive-perceptual symptoms short-term.
• SSRIs treat comorbid depression and anxiety but do not address core BPD features, so avoid reflexive polypharmacy and long-term sedative prescribing.
• Benzodiazepines can disinhibit and increase self-harm, so limit quantities dispensed and review overdose risk for every agent prescribed.

Psychotherapy

• DBT over 12 months with weekly individual therapy, skills group, phone coaching and a consultation team has the strongest randomized trial evidence.
• MBT and transference-focused psychotherapy produce comparable gains, supporting a structured, well-boundaried frame over any single brand.
• Good psychiatric management is a generalist model teachable in a day and shown non-inferior to DBT in a Canadian randomized trial.
• Schema therapy and STEPPS add further options, and all effective models share a clear frame, explicit crisis planning and therapist consultation.
• Expect one to two years of treatment, with early gains in self-harm and hospitalization preceding improvement in identity and functioning.

Adjunct options

• Favor brief crisis stabilization over extended inpatient stays, which can reinforce regression and interrupt outpatient skills learning.
• Written crisis and safety plans, means restriction and explicit between-session contact rules measurably reduce emergency presentations.
• Family psychoeducation such as Family Connections lowers caregiver burden and criticism, improving the patient's interpersonal environment.
• Track outcome with the BSL-23, DERS or the Zanarini rating scale, and monitor self-harm frequency rather than subjective distress alone.
• Address vocational rehabilitation and social role functioning, which lag behind symptom remission by years in longitudinal follow-up data.

Clinical pearls

• Mood shifts in hours, not weeks; that timing separates BPD instability from bipolar II.
• Most patients remit: roughly 85% no longer meet criteria at 10 years of follow-up.
• Prescribe less and structure more; polypharmacy is the commonest iatrogenic harm here.